BPIFB4 and cardiovascular disorder: Previous work documented the potential of LAV-BPIFB4 gene therapy for the treatment of cardiovascular diseases and cardiomyopathies [20, 23, 24], More recently, we have gained evidence for the similar therapeutic value of directly using the encoded protein.